EQL Pharma AB (FRA:7JK) FCF Margin % : 68.68% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. EQL Pharma AB's Free Cash Flow for the three months ended in Mar. 2024 was €4.74 Mil. EQL Pharma AB's Revenue for the three months ended in Mar. 2024 was €6.90 Mil. Therefore, EQL Pharma AB's FCF Margin % for the quarter that ended in Mar. 2024 was 68.68%.

As of today, EQL Pharma AB's current FCF Yield % is -0.88%.

The historical rank and industry rank for EQL Pharma AB's FCF Margin % or its related term are showing as below:

FRA:7JK' s FCF Margin % Range Over the Past 10 Years
Min: -78.64 Med: -18.13 Max: 7.22
Current: -4.51

During the past 12 years, the highest FCF Margin % of EQL Pharma AB was 7.22%. The lowest was -78.64%. And the median was -18.13%.

FRA:7JK's FCF Margin % is ranked worse than
60.99% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs FRA:7JK: -4.51

EQL Pharma AB FCF Margin % Historical Data

The historical data trend for EQL Pharma AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB FCF Margin % Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

-15.83

2.49

4.82

7.22

-4.55

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															30.58	-34.71	-6.57	-60.19	68.68

Competitive Comparison of EQL Pharma AB's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EQL Pharma AB's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's FCF Margin % falls into.

EQL Pharma AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

EQL Pharma AB's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-1.062	/	23.343
	=	-4.55 %

EQL Pharma AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	4.742	/	6.904
	=	68.68 %

EQL Pharma AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines